Phreesia is a medical - healthcare information services company in the healthcare sector trading on NYSE, led by CEO Chaim Indig, with a market cap of $662.0M.
Upcoming earnings announcement for Phreesia
Past 11 earnings reports for Phreesia
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Dec 8, 2025 | Q3 2026 | $0.07Est: $0.24 | -70.8% | $120.3MEst: $120.1M | +0.2% | |
| Sep 4, 2025 | Q2 2026 | $0.01Est: $0.09 | -88.9% | $117.3MEst: $116.4M | +0.7% | |
| May 28, 2025 | Q1 2026 | -$0.07Est: $0.16 | -143.8% | $115.9MEst: $115.0M | +0.8% | |
| Mar 12, 2025 | Q4 2025 | -$0.11Est: -$0.19 | +42.1% | $109.7MEst: $108.9M | +0.7% | |
| Dec 9, 2024 | Q3 2025 | -$0.25Est: -$0.29 | +13.8% | $106.8MEst: $106.0M | +0.8% | |
| Sep 4, 2024 | Q2 2025 | -$0.31Est: -$0.36 | +13.9% | $102.1MEst: $101.7M | +0.4% | |
| May 30, 2024 | Q1 2025 | -$0.35Est: -$0.48 | +27.1% | $101.2MEst: $101.0M | +0.2% | |
| Mar 14, 2024 | Q4 2024 | -$0.56Est: -$0.26 | -115.4% | $95.0MEst: $93.5M | +1.6% | |
| Dec 5, 2023 | Q3 2024 | -$0.58Est: -$0.36 | -61.1% | $91.6MEst: $89.7M | +2.2% | — |
| Sep 6, 2023 | Q2 2024 | -$0.68Est: -$0.42 | -61.9% | $85.8MEst: $85.2M | +0.7% | |
| May 31, 2023 | Q1 2024 | -$0.70Est: -$0.46 | -52.2% | $83.8MEst: $81.2M | +3.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.